CORD-19:867ebb2be2d466bcb35e5a7319708eaff39c4799 / 333084-333287 JSONTXT

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T363","span":{"begin":0,"end":11},"obj":"Sentence"},{"id":"T364","span":{"begin":12,"end":203},"obj":"Sentence"}],"text":"Background: The empirical combination of both a beta-lactam and glycopeptide to counter potential staphylococcal pathogens may improve the clinical outcomes for cases of Staphylococcus aureus bacteremia."}

{"project":"CORD-19-Sentences","denotations":[{"id":"T51925","span":{"begin":0,"end":11},"obj":"Sentence"},{"id":"T62894","span":{"begin":12,"end":203},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Background: The empirical combination of both a beta-lactam and glycopeptide to counter potential staphylococcal pathogens may improve the clinical outcomes for cases of Staphylococcus aureus bacteremia."}

{"project":"Epistemic_Statements","denotations":[{"id":"T541","span":{"begin":0,"end":203},"obj":"Epistemic_statement"}],"text":"Background: The empirical combination of both a beta-lactam and glycopeptide to counter potential staphylococcal pathogens may improve the clinical outcomes for cases of Staphylococcus aureus bacteremia."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T748","span":{"begin":192,"end":202},"obj":"Phenotype"}],"attributes":[{"id":"A748","pred":"hp_id","subj":"T748","obj":"http://purl.obolibrary.org/obo/HP_0031864"}],"text":"Background: The empirical combination of both a beta-lactam and glycopeptide to counter potential staphylococcal pathogens may improve the clinical outcomes for cases of Staphylococcus aureus bacteremia."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T1671","span":{"begin":192,"end":202},"obj":"Disease"},{"id":"T44979","span":{"begin":192,"end":202},"obj":"Disease"}],"attributes":[{"id":"A1671","pred":"mondo_id","subj":"T1671","obj":"http://purl.obolibrary.org/obo/MONDO_0005229"},{"id":"A72552","pred":"mondo_id","subj":"T44979","obj":"http://purl.obolibrary.org/obo/MONDO_0005229"}],"text":"Background: The empirical combination of both a beta-lactam and glycopeptide to counter potential staphylococcal pathogens may improve the clinical outcomes for cases of Staphylococcus aureus bacteremia."}